GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Varian Medical Systems, Inc. (VAR) [hlAlert]

Rating:
Outperform
VAR
up 6.50 %

Varian Medical Systems, Inc. (VAR) rated Outperform with price target $91 by Barrington Research

Posted on: Tuesday,  Jan 12, 2016  10:25 AM ET by Barrington Research

Barrington Research rated Outperform Varian Medical Systems, Inc. (NYSE: VAR) on 01/12/2016, when the stock price was $76.82.
Since then, Varian Medical Systems, Inc. has gained 6.51% as of 01/12/2016's recent price of $81.82.
If you would have followed this Barrington Research's recommendation on VAR, you would have gained 6.5% of your investment in 0 days.

Varian Medical Systems, Inc., of Palo Alto, California is the world's leading supplier of equipment and software for treating cancer. The company is also a premier supplier of components including X-ray tubes and flat-panel detectors for medical, scientific, and industrial imaging. Varian Medical Systems employs approximately three thousand nine hundtre people who are located at manufacturing sites in North America and Europe and in its 55 sales and support offices around the world.

As our name implies, research plays a central role in everything we do. Whether we're dealing with sales, trading, investment banking or asset management, insightful research is indispensable in providing value to our clients. Our research provides us with a comprehensive understanding of the economy, financial markets, and individual companies, all of which are essential in recommending successful investments.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/12/2016 10:25 AM Buy
None
76.82 91.00
as of 8/27/2015
1 Week down  -3.83 %
1 Month down  -6.33 %
3 Months down  -6.58 %
1 YTD up  5.31 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/2/2012 8:25 AM Buy
None
65.18
9/15/2009 3:25 PM Hold
None
43.97
4/13/2009 10:25 AM Buy
None
33.01 45.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy